Differential response of bipolar and normal control lymphoblastoid cell sodium pump to ethacrynic acid.

[1]  S. Khanna,et al.  Erythrocyte membrane sodium — potassium adenosine triphosphatase activity in affective disorders , 2005, Journal of Neural Transmission / General Section JNT.

[2]  R. El-Mallakh,et al.  Mood stabilizers and ion regulation. , 2001, Harvard review of psychiatry.

[3]  S. Parikh,et al.  Associated disturbances in calcium homeostasis and G protein–mediated cAMP signaling in bipolar I disorder , 2000, Biological Psychiatry.

[4]  R. S. Levy,et al.  Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  G. Moore,et al.  Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. , 1999, The Journal of clinical psychiatry.

[6]  J. Kleinman,et al.  Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals , 1998, Biological Psychiatry.

[7]  R. S. Levy,et al.  Persistent Hyperactivity Following a Single Intracerebroventricular Dose of Ouabain , 1998, Physiology & Behavior.

[8]  S. Looney,et al.  Meta‐analysis of erythrocyte Na,K‐ATPase activity in bipolar illness , 1997, Depression and anxiety.

[9]  J. Warsh,et al.  Second messenger systems and mood disorders , 1996 .

[10]  S. Looney,et al.  Nerve conduction velocity and H-reflex recovery in bipolar illness. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[11]  R. Wyatt,et al.  The Na,K-ATPase hypothesis for bipolar illness , 1995, Biological Psychiatry.

[12]  R. El-Mallakh,et al.  Is the Na(+)-K(+)-ATPase the link between phosphoinositide metabolism and bipolar disorder? , 1993, The Journal of neuropsychiatry and clinical neurosciences.

[13]  P. Cowen,et al.  Altered in vitro adaptive responses of lymphocyte Na+,K(+)-ATPase in patients with manic depressive psychosis. , 1991, Journal of affective disorders.

[14]  R. El-Mallakh,et al.  Calcium Channel Blockers in Affective Illness: Role of Sodium‐Calcium Exchange , 1990, Journal of clinical psychopharmacology.

[15]  F. Goodwin.  Manic-Depressive Illness , 1990 .

[16]  K. Kidd,et al.  Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish , 1989, Nature.

[17]  S. Avissar,et al.  Muscarinic receptor subclassification and G-proteins: Significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics , 1989, Biological Psychiatry.

[18]  K. Kidd,et al.  Bipolar affective disorders linked to DNA markers on chromosome 11 , 1987, Nature.

[19]  D. Alexander,et al.  Sodium-potassium, magnesium, and calcium ATPase activities in erythrocyte membranes from manic-depressive patients responding to lithium , 1986, Biological Psychiatry.

[20]  S. Dubovsky,et al.  Intracellular calcium ions in affective disorders: a review and an hypothesis. , 1983, Biological psychiatry.

[21]  G. Naylor,et al.  Defective genetic control of sodium-pump density in manic depressive psychosis , 1981, Psychological Medicine.

[22]  J. Feighner,et al.  Diagnostic criteria for use in psychiatric research. , 1972, Archives of general psychiatry.

[23]  D. M. Shaw.  Mineral metabolism, mania, and melancholia. , 1966, British medical journal.

[24]  A. Coppen,et al.  Mineral metabolism in mania. , 1966, British medical journal.